BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 214 filers reported holding BEAM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,449,516 | -44.7% | 143,431 | -26.6% | 0.00% | -33.3% |
| Q2 2023 | $6,243,305 | +105539.7% | 195,531 | +1.3% | 0.00% | 0.0% |
| Q1 2023 | $5,910 | +90.9% | 193,000 | +143.8% | 0.00% | +50.0% |
| Q4 2022 | $3,096 | -100.0% | 79,154 | -57.2% | 0.00% | -60.0% |
| Q3 2022 | $8,809,000 | -43.2% | 184,905 | -53.8% | 0.01% | -50.0% |
| Q2 2022 | $15,498,000 | -53.2% | 400,363 | -30.7% | 0.01% | -44.4% |
| Q1 2022 | $33,123,000 | +195.5% | 578,061 | +311.0% | 0.02% | +200.0% |
| Q4 2021 | $11,208,000 | -43.3% | 140,650 | -38.0% | 0.01% | -50.0% |
| Q3 2021 | $19,750,000 | +60.3% | 226,989 | +137.2% | 0.01% | +50.0% |
| Q2 2021 | $12,317,000 | -17.0% | 95,695 | -50.7% | 0.01% | -27.3% |
| Q1 2021 | $14,836,000 | +308.6% | 194,295 | +336.9% | 0.01% | +266.7% |
| Q4 2020 | $3,631,000 | -61.7% | 44,471 | -86.9% | 0.00% | -76.9% |
| Q2 2020 | $9,482,000 | +147.2% | 338,645 | +58.9% | 0.01% | +44.4% |
| Q1 2020 | $3,836,000 | – | 213,105 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |